Precision Medicine in Oncology
โ๐Are you passionate about cancer research and excited by translation and entrepreneurship? ๐
โJoin us at the Francis Crick Institute on Tuesday 18th March for our Precision Medicine in Oncology event!
โCSEN have partnered with Cancer Research UK (CRUK), Cancer Research Horizons (CRH), Capital Enterprise, and Cancer Tech Accelerator (CTA) for an afternoon of talks, discussions, networking!
โ๐ Date: 18th March 2025
โโฐ Time: 2:00 โ 7:00pm
โ๐ Location: Francis Crick Institute, 1 Midland Rd, London, NW1 1AT
โOur line up includes:
โโKeynote from world renowned researcher and entrepreneur Professor Allan Bradley (founder & CEO of T-Therapeutics, Emeritus Director of the Wellcome Trust Sanger Institute) talking about how he translated his discoveries into impact.
โShort talks from scientists who have commercialised their research:
โ๐งฌ Annelise Soulier Co-Founder & CSO at Neobe Therapeutics
โ๐งฌ Skomer Bennett-Clemmow Co-Founder & CEO at Gena Health
โ๐งฌ Miguel Gonzalez Canudas, PhD Chief AI Officer & Co-Founder at PentaBind
โAn exciting panel discussion about charting the pathways to patient impact:
โ๐งฌ Joseph Lehรกr โ Advisor for multiple biotechs
โ๐งฌ Tanya Moore โ Investment Principal at Cancer Research Horizons
โ๐งฌ Jonathan Grinbaudย โ Project Manager at Innovate UK
โ๐ค Alessia Errico PhD MBA โ Associate Director for Search & Evaluation and Entrepreneurial Programmes Lead at CRUK
โPreliminary schedule:
โ14:00-14:30: Registration
โ14:30-14:45: Welcome and introductions to partners
โ14:45-15:30: Keynote: Prof Allan Bradley, T-Therapeutics
โ15:30-16:15: Short talks, 4x10 mins
โ16:15-16:45: Coffee break
โ16:45-17:30: Panel discussion: Charting the Pathways to Patient Impact
โ17:30-19:00: Drinks reception and networking